Chronic Condition Management

A real-world study confirms the effectiveness and safety of the all-oral combination of sofosbuvir plus ribavirin for treatment of hepatitis C virus GT2 infection.

U.S. study finds those with HCV three times more likely to drink five or more drinks per day every day vs. those without HCV infections.

HCVcAg tests may cost less and improve diagnostic capacity in settings of high hepatitis C virus prevalence, according to new research.

Removing potential barriers to treat hepatitis C virus is yet another key component to patient access, notes lead researcher.

Lead researcher says economic impact of hepatitis C virus will increase unless action is taken now.

States had restricted Medicaid recipients’ access to drugs, but new court rulings are changing that practice.

Researchers find that direct-acting antivirals are better tolerated in patients with hepatitis C virus infections vs. interferon-based therapy.

PCPs can “play a decisive role in eradicating” hepatitis C virus in the U.S., says lead author of new study.

After initial investment, approach could help reduce outpatient and professional costs while maintaining or improving outcomes, new study says.

New data suggest that neighborhood environments have significant effects on health.

A new report finds that hepatitis B and C can be eliminated as a public health problem.

A new study highlights the need for hepatitis C virus screening of pregnant women to identify HCV-infected children and direct them to proper care. A significant number of babies born to women who are infected with the hepatitis C virus (HCV) remain untested for perinatal infections, according to a new study.

The protease and polymerase inhibitor proved effective and well tolerated in patients with hepatitis C virus and cirrhosis, according to a new study.

Community-based program helped beneficiaries lose weight and learn healthy diet and physical activity habits, according to federal agency.

Lifestyle counseling program would be first to be eligible for expansion to all Medicare beneficiaries under the Affordable Care Act.

Direct-acting antiviral (DAA) agents appear to have a less robust effect in “difficult-to-treat” patients, according to new research.

A new study explores what lifestyle hepatitis C virus (HCV) patients consider when directing their course of treatement.

Electronic health records could be an untapped resource for helping to identify patients with undiagnosed type 2 diabetes.

The effects of blood pressure treatment in people with type 2 diabetes may depend on the blood pressure level prior to treatment.

A new study indicates that infection with the hepatitis C virus (HCV) significantly increases the risk of developing Parkinson’s Disease.

The use of sofosbuvir and velpatasvir successfully treated hepatitis C virus infection in 90% of advanced liver disease patients, a new study notes.

A new study finds that novel direct-acting antiviral therapies might reduce the prevalence of hepatitis C virus and, with enhanced screening and treatment, potentially end infections altogether.

Treating hepatitis C virus (HCV) infection at early stages of fibrosis improves health outcomes and is cost-effective, a new study finds.

An easy, cost-effective, one-step test can allow clinicians to screen, detect, and confirm hepatitis C virus (HCV) infections, according to a new study.

Nearly half of all Medicaid claims for direct-acting antiviral drugs to treat chronic hepatitis C virus infections have been denied in four states recently because they were not considered “a medical necessity,” according to a new study.